The Pathogenesis and Prognostic Factors of Lymphoma

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
LymphomaHodgkin LymphomaNon-hodgkin Lymphoma
Interventions
OTHER

Real-world regimen

The final personalized management strategy is determined based on current conventional treatment options, physician and patient preferences.The following protocols: chemotherapy, immunochemotherapy,Anti-cd20 monoclonal antibody, BTKi and so on

Trial Locations (1)

200032

RECRUITING

Zhongshan Hospital,Fudan University, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER